The Drug Enforcement Administration (DEA) has refused once more to a petition from a doctor to treat terminally-ill patients with psilocybin therapy, following federal and state “Right to Try” (RTT) laws. The agency is being takento court in a new case.
A preceding litigation took place in the U.S. Ninth Circuit Court of Appeals in February 2022. In light of the court’s case dismissal on procedural grounds, the plaintiffs further pointed at the DEA for a clarification. As the agency did not respond, the case attorneys set a date—until last week—to hold for its reply, after which they would send in another lawsuit.
